Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.

Home
Find People
Find Everything
About This Site
Annual Report
Export RDF

Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.

Sutter ME, Gaedigk A, Albertson TE, Southard J, Owen KP, Mills LD, Diercks DB. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure. Clin Toxicol (Phila). 2013 Aug; 51(7):540-4.

View in: PubMed

subject areas

Adult
Amphetamine-Related Disorders
Biomarkers
Cardiomyopathy, Dilated
Case-Control Studies
Central Nervous System Stimulants
Chi-Square Distribution
Cytochrome P-450 CYP2D6
Female
Gas Chromatography-Mass Spectrometry
Genetic Predisposition to Disease
Heart Failure
Humans
Logistic Models
Male
Methamphetamine
Middle Aged
Natriuretic Peptide, Brain
Odds Ratio
Phenotype
Pilot Projects
Polymorphism, Genetic
Predictive Value of Tests
Prospective Studies
Risk Assessment
Risk Factors
Substance Abuse Detection

authors with profiles

Andrea Gaedigk